752
F. Z. EL-ABLACK et al.
Pharmacology
A solution of the tested compounds in acetone (1 mg/mL) was added to the nutrient agar (for
bacteria) or medium (for fungi) mixed well and poured on plates, the tested organism was
then streaked on the surface of agar or medium was incubated at 37 ºC for 24 h (bacteria)
and 28 ºC for 48 h (fungi) and the growth was recorded the organism used were S. Aurous,
S. Albus, E. Coli in addition to yeast (Table 2).
Table 2. In vitro biological activity of the compounds (2, 6, 7, 8, 9)
Compound
S. Albus
S.aureus
50
E.coli
-
Yeast
-
50
β
.subtities
-
50
50
-
-
50
2
6
7
8
9
-
100
100
-
-
100
50
100
100
100
100
100
50
100
100
Table 3. Spectral data of synthesized compounds
IR. cm-1 (KBr)
1H NMR. δ(ppm)
Compd
3095(CH aromatic), 2965 (CH3), 2890
(CH2), 1675 (C=O), 1620 (C=N).
3410(NH); 2995 (CH aromatic);2885(CH2) 2.03 (s, 3H. CH3); 2.89 (s, 2H. CH2); 7.43-
1.05 (s, 3H. CH3); 3.78 (s, 2H. CH2); 2.6 (s,
2H. CH2).7.24 (m, 4H, ArH).
2
3
4
2930( CH3);1680(C=O); 1620(C=N).
3042 (CH aromatic); 2965-2980 (CH3);
2890 (CH2); 1625 (C=N); 1610 (C=C).
3050 (CH aromatic); 3345 (NH2); 2895
(CH2); 1680 (C=O); 1628 (C=N).
7.65 (m, 9H, ArH), 8.81 (s, H, NH)
1.13(s, 6H. CH3); 2.65(s, 2H. CH2); 7.1-7.7
(m, 4H, ArH)); 5.1 (s, H, CH olefinic)
2.4(s, 2H. CH2); 2.8 (s, 2H, CH2) 7.1-7.7 (m,
4H. ArH); 6.5 (s, 2H, NH2)
5
3330(NH); 3095(CH aromatic);2930(CH3); 2.03(s, 3H. CH3); 3.8 (s, 2H. CH2); 7.1-7.6
6
2896(CH2); 1626(C=N);1200-1250(C-N-C).
3415 (NH); 3096 (CH aromatic); 2875
(CH2); 1620 (C=N).
(m, 9H. ArH); 2.1 (s, 1H, NH).
7.12-7.67 (m, 14H, ArH); 3.8 (s, 2H, CH2);
2 (s, 1H, NH).
7
3445 (NH), 3095 (CH Aromatic), 2870 7.23-7.63( m, 4H, ArH); 3.43 (s, 2H, CH2);
(CH2), 1624 (C=N) 2.3 (s, 1H, NH);1.56-2.2 (CH2 cyclopetane)
3335 (NH); 3045 (CH aromatic);2899(CH3); 3.4(S, 2H, 2CH2); 4.46 (S, 2H, CH2); 7.26-
8
9
2880(CH2); 1680(C=O);1620 (C=N).
3100 (ArH), 2910 (CH2), 3085 (=C-H),
1628 ( C=N).
7.65 ( m, 4H, ArH); 8.15 (S, 1H, NH)
7.06-7.62 ( m, 14H, ArH), 5.01 (s, 1H, CH
olefinic), 4.79 (s, 2H, CH2)
10
References
1.
2.
3.
Menon M K, Clark W G and Ures D A, Eur J Pharmacol.,1972, 19, 43-51.
Pandey V K and Agarwat A K, J Indian Chem Soc., 1981, 58, 306-307.
Spasov A A, Yozhitsa I N, Bugaeva L I and Anisimova V A, Pharm Chem J., 1999,
33, 232-243.
4.
a) Gravatt G L, Baguley B C, Wilson W R and Denny W A, J Med Chem., 1994, 37,
4338-4345;. b) Jayashankara B and Rai K M L, ARKIVOC, 2008, 11, 75.
El-Ablack F Z, Etmann H A, Metwally M A and Amer F A, Pharmzie, 1995, 50(3), 222-224.
El-Ablack F Z, Etman H A and Metwally M A, Boll Chim Farmaceutico.,1995, 134, 77-79.
Mohareb R M, Wardakhan W W and El-Ablack F Z, J Chem Res (M), 1994, 747-760.
El-Ablack F Z, Boll Chi Farmac., 2003, 9, 142.
5.
6.
7.
8.
9.
Reddy B S, Reddy R B, Chandramouli G V P and Reddy Y D, J Indian Chem Soc.,
1988, 65, 853-854.